300937 Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical
- 21.30
- -0.39-1.80%
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical News
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical: 300937 Pharma Tesco Investor Relations Management Information 20240521
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical: Announcement on holding the 2023 online results briefing
Pharma Tesco: Announcement on the Company and its subsidiaries applying for comprehensive credit lines from banks and accepting guarantees from related parties in 2024
Pharma Tesco: 2023 Non-Recurring Profit and Loss Statement Verification Report
Medico-Tesco: Announcement of Board Resolutions
Pharma Tesco: 2023 Independent Director Debriefing Report (Liu Lei)
E-Commerce: Special Report on the Storage and Use of Funds Raised in 2023
Medicinal Tesco: Opinions of Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. on the use of idle funds by Sichuan Hesong Pharmaceutical Co., Ltd. for cash management
Pharma Tesco: 2023 Independent Director Debriefing Report (Luo Xiang)
Medicinal Tesco: Special Inspection Report of Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. on the storage and use of funds raised by Sichuan Hezong Pharmaceutical Co., Ltd. in 2023
Pharma Tesco: 2023 Internal Control Verification Report
Pharma Tesco: Report on the work of the Supervisory Committee in 2023
Medico-eShop: 2023 Annual Audit Report
Tesco Pharmaceuticals: Supervisory Board Resolutions Announced
Medicago: Announcement on providing guarantees for subsidiaries to apply for credit
Pharma Tesco: The Board's Special Opinion on the Independent Director's Evaluation
Pharma Tesco: 2023 Independent Director Debriefing Report (Dan Bov)
Medicinal Tesco: Opinions of Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. on the inspection of Sichuan Hesong Pharmaceutical Co., Ltd. and subsidiaries applying for credit lines from banks and accepting guarantees from related parties
Pharma Tesco: Announcement on the Renewal of the 2024 Audit Institution
Medicinal Tesco: Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd.'s 2023 follow-up report on Sichuan Hesong Pharmaceutical Co., Ltd.
Analysis
Price Target
No Data
